{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T09:10:24Z","timestamp":1772183424596,"version":"3.50.1"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Faculty of Medicine, Khon Kaen University","award":["IN63254"],"award-info":[{"award-number":["IN63254"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Lower urinary tract symptoms (LUTS) are common in SSc. The severity of symptoms can affect the quality of life (QOL); however, LUTS is often neglected during routine assessments. We determined the prevalence of moderate to severe LUTS in SSc and its associated factors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A cross-sectional study was conducted between March 2020 and June 2020. Adult SSc patients were enrolled from the Scleroderma Clinic, Khon Kaen University, Thailand. All completed a self-administered questionnaire on LUTS using the International Prostate Symptom Score (IPSS), categorized into absent, mild, moderate or severe LUTS. In addition, we investigated the factors associated with moderate to severe LUTS, and the correlation between IPSS-QOL score and IPSS severity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 135 patients were enrolled. Most cases were female (87 cases; 64.4%) and had dcSSc (88 cases; 65.2%). Twenty-six were defined as having moderate to severe LUTS, for a prevalence of 19.3% (95% CI 13.0, 26.9%). In addition, most had storage symptoms (63.0%), followed by voiding symptoms (19.3%) and post-voiding symptoms (12.6%). The factors associated with moderate to severe LUTS per the multivariable logistic regression included a modified Rodnan skin score \u226520 points and gastrointestinal symptoms with adjusted odds ratios 7.64 and 5.78, respectively. In addition, the IPSS-QOL score had a moderate positive correlation with IPSS severity (rho\u2009=\u20090.560, P\u2009&amp;lt;\u20090.001).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Moderate to severe LUTS occurred in about one-fifth of SSc patients, particularly those with extensive skin tightness and gastrointestinal involvement. The more severe the LUTS, the poorer the QOL.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keac052","type":"journal-article","created":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T20:14:05Z","timestamp":1643314445000},"page":"4016-4023","source":"Crossref","is-referenced-by-count":3,"title":["Prevalence of moderate to severe lower urinary tract symptoms in systemic sclerosis"],"prefix":"10.1093","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2360-3088","authenticated-orcid":false,"given":"Ukrit","family":"Rompsaithong","sequence":"first","affiliation":[{"name":"Division of Urology, Department of Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wichien","family":"Sirithanaphol","sequence":"additional","affiliation":[{"name":"Division of Urology, Department of Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajanee","family":"Mahakkanukrauh","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Faculty of Medicine, Khon Kaen University , Khon Kaen, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siraphop","family":"Suwannaroj","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Faculty of Medicine, Khon Kaen University , Khon Kaen, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chingching","family":"Foocharoen","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Faculty of Medicine, Khon Kaen University , Khon Kaen, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,2,2]]},"reference":[{"key":"2022100812083469000_keac052-B1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.rdc.2015.04.002","article-title":"The pathogenesis of systemic sclerosis","volume":"41","author":"Stern","year":"2015","journal-title":"Rheum Dis Clin North Am"},{"key":"2022100812083469000_keac052-B2","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U","article-title":"Severe organ involvement in systemic sclerosis with diffuse scleroderma","volume":"43","author":"Steen","year":"2000","journal-title":"Arthritis Rheum"},{"key":"2022100812083469000_keac052-B3","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S0022-5347(01)67546-3","article-title":"Vesical dysfunction in systemic sclerosis (scleroderma)","volume":"153","author":"Lazzeri","year":"1995","journal-title":"J Urol"},{"key":"2022100812083469000_keac052-B4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000019678","article-title":"Bladder involvement in systemic sclerosis: urodynamic and histological evaluation in 23 patients","volume":"34","author":"Minervini","year":"1998","journal-title":"Eur Urol"},{"key":"2022100812083469000_keac052-B5","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/nau.23897","article-title":"The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction","volume":"38","author":"D\u2019Ancona","year":"2019","journal-title":"Neurourol Urodyn"},{"key":"2022100812083469000_keac052-B6","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/acr.23454","article-title":"Prevalence and disease-specific risk factors for lower urinary tract symptoms in systemic sclerosis: an international multicenter study","volume":"70","author":"John","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2022100812083469000_keac052-B7","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1016\/j.lpm.2015.08.009","article-title":"Systemic sclerosis: sexual dysfunction and lower urinary tract symptoms in 73 patients","volume":"45","author":"Sanchez","year":"2016","journal-title":"Presse Med"},{"key":"2022100812083469000_keac052-B8","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0022-5347(17)36966-5","article-title":"The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association","volume":"148","author":"Barry","year":"1992","journal-title":"J Urol"},{"key":"2022100812083469000_keac052-B9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0090-4295(01)01300-0","article-title":"Evaluation of symptoms and quality of life in men with benign prostatic hyperplasia","volume":"58","author":"Barry","year":"2001","journal-title":"Urology"},{"key":"2022100812083469000_keac052-B10","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/S0022-5347(17)35872-X","article-title":"American Urological Association symptom index for women with voiding symptoms: lack of index specificity for benign prostate hyperplasia","volume":"150","author":"Chancellor","year":"1993","journal-title":"J Urol"},{"key":"2022100812083469000_keac052-B11","first-page":"1064","article-title":"Reliability of Thai-version Overactive Bladder Symptom Scores (OABSS) questionnaire and the correlations of OABSS with voiding diary, International Prostate Symptom Score (IPSS), and Patient Perception of Bladder Condition (PPBC) questionnaires","volume":"98","author":"Bunyavejchevin","year":"2015","journal-title":"J Med Assoc Thail Chotmaihet Thangphaet"},{"key":"2022100812083469000_keac052-B12","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/S0022-5347(01)66780-6","article-title":"Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients?","volume":"154","author":"Barry","year":"1995","journal-title":"J Urol"},{"key":"2022100812083469000_keac052-B13","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa030656","article-title":"The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia","volume":"349","author":"McConnell","year":"2003","journal-title":"N Engl J Med"},{"key":"2022100812083469000_keac052-B14","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0090-4295(94)80165-7","article-title":"Natural history of prostatism: impact of urinary symptoms on quality of life in 2115 randomly selected community men","volume":"44","author":"Girman","year":"1994","journal-title":"Urology"},{"key":"2022100812083469000_keac052-B15","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2022100812083469000_keac052-B16","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J. Rheumatol"},{"key":"2022100812083469000_keac052-B17","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/BOR.0000000000000711","article-title":"Management of systemic sclerosis: the first five years","volume":"32","author":"Roofeh","year":"2020","journal-title":"Curr Opin Rheumatol"},{"key":"2022100812083469000_keac052-B18","first-page":"1281","article-title":"Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis","volume":"22","author":"Clements","year":"1995","journal-title":"J. Rheumatol"},{"key":"2022100812083469000_keac052-B19","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/1346-8138.14162","article-title":"Diagnostic criteria, severity classification and guidelines of systemic sclerosis","volume":"45","author":"Asano","year":"2018","journal-title":"J Dermatol"},{"key":"2022100812083469000_keac052-B20","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1002\/1529-0131(200011)43:11<2445::AID-ANR11>3.0.CO;2-Q","article-title":"Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial","volume":"43","author":"Clements","year":"2000","journal-title":"Arthritis Rheum"},{"key":"2022100812083469000_keac052-B21","doi-asserted-by":"crossref","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur Respir J"},{"key":"2022100812083469000_keac052-B22","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.mcna.2014.01.012","article-title":"Involuntary weight loss","volume":"98","author":"Wong","year":"2014","journal-title":"Med Clin North Am"},{"key":"2022100812083469000_keac052-B23","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/JU.0000000000001297","article-title":"Microhematuria: AUA\/SUFU guideline","volume":"204","author":"Barocas","year":"2020","journal-title":"J Urol"},{"key":"2022100812083469000_keac052-B24","first-page":"615","article-title":"Reliability of a Thai version of the International Prostate Symptom Score (IPSS) for the Thai population","volume":"97","author":"Nontakaew","year":"2014","journal-title":"J Med Assoc Thail Chotmaihet Thangphaet"},{"key":"2022100812083469000_keac052-B25","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1464-410X.2004.04930.x","article-title":"Prevalence of lower urinary tract symptoms in men aged 45-79 years: a population-based study of 40 000 Swedish men","volume":"94","author":"Andersson","year":"2004","journal-title":"BJU Int"},{"key":"2022100812083469000_keac052-B26","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1464-410X.2005.05573.x","article-title":"The prevalence and correlates of urinary tract symptoms in Norwegian men: the HUNT study","volume":"96","author":"Seim","year":"2005","journal-title":"BJU Int"},{"key":"2022100812083469000_keac052-B27","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1464-410X.2009.08427.x","article-title":"The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study","volume":"104","author":"Coyne","year":"2009","journal-title":"BJU Int"},{"key":"2022100812083469000_keac052-B28","doi-asserted-by":"crossref","first-page":"166","DOI":"10.4111\/icu.2018.59.3.166","article-title":"The prevalence of lower urinary tract symptoms in population aged 40 years or over, in South Korea","volume":"59","author":"Yoo","year":"2018","journal-title":"Investig Clin Urol"},{"key":"2022100812083469000_keac052-B29","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10067-019-04714-y","article-title":"Systemic sclerosis and urinary symptoms: a complex pathophysiology","volume":"39","author":"John","year":"2020","journal-title":"Clin Rheumatol"},{"key":"2022100812083469000_keac052-B30","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/BF02230326","article-title":"Premictional volume and contractility of the urinary bladder in patients with systemic sclerosis","volume":"15","author":"Kucharz","year":"1996","journal-title":"Clin Rheumatol"},{"key":"2022100812083469000_keac052-B31","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/ajg.2011.399","article-title":"Fecal incontinence in systemic sclerosis is secondary to neuropathy","volume":"107","author":"Thoua","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"2022100812083469000_keac052-B32","doi-asserted-by":"crossref","first-page":"G1206","DOI":"10.1152\/ajpgi.00286.2009","article-title":"Immunoglobulins from scleroderma patients inhibit the muscarinic receptor activation in internal anal sphincter smooth muscle cells","volume":"297","author":"Singh","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2022100812083469000_keac052-B33","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/1756-185X.13859","article-title":"Clinical characteristics and outcomes of 566 Thais with systemic sclerosis: a cohort study","volume":"23","author":"Foocharoen","year":"2020","journal-title":"Int J Rheum Dis"},{"key":"2022100812083469000_keac052-B34","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1093\/rheumatology\/kex230","article-title":"The limited cutaneous form of systemic sclerosis is associated with urinary incontinence: an international multicentre study","volume":"56","author":"John","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2022100812083469000_keac052-B35","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10067-019-04551-z","article-title":"Comparison of clinical presentation and incidence of cardiopulmonary complications between male and female Thai patients with early systemic sclerosis: inception cohort study","volume":"39","author":"Wangkaew","year":"2020","journal-title":"Clin Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keac052\/42533692\/keac052.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/10\/4016\/46382896\/keac052.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/10\/4016\/46382896\/keac052.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T12:10:14Z","timestamp":1665231014000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/61\/10\/4016\/6520423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,2]]},"references-count":35,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,2,2]]},"published-print":{"date-parts":[[2022,10,6]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keac052","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,10,1]]},"published":{"date-parts":[[2022,2,2]]}}}